Keebeck Alpha, LP Moderna, Inc. Transaction History

Keebeck Alpha, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Feb 01, 2023	BUY	$117.13 - $176.59 $25,417 - $38,320	217 Added 5.37%	4,256 $608,000
Q2 2022 Aug 08, 2022	BUY	$117.13 - $176.59 $25,417 - $38,320	217 Added 5.37%	4,256 $608,000
Q1 2022 Feb 01, 2023	SELL	$126.46 - $235.05 $27,441 - $51,005	-217 Reduced 5.1%	4,039 $696,000
Q4 2021 Feb 09, 2022	BUY	$225.82 - $368.51 $303,953 - $496,014	1,346 Added 49.98%	4,039 $1.03 Million
Q4 2020 Feb 05, 2021	BUY	$65.74 - $169.86 $177,037 - $457,432	2,693 New	2,693 $281,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

Stay updated on Keebeck Alpha, LP with notifications on news.